CompletedNCT03257865
Brexpiprazole or Placebo for Acute Mania in Bipolarity
About this title
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
Read the official source — NCT03257865Researchers compared Brexpiprazole and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.
Medication studyAges 18–65Multiple countries
Understand this study
What did researchers investigate?
Researchers compared Brexpiprazole and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Little Rock and 37 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: September 19, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 333
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Croatia, Ukraine
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03257865
- Official title
Show the full official title
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Get this study by email
Recruitment & locations
CompletedLittle Rock, United States · Bellflower, United States · Cerritos, United States
31 more locations
- Long Beach, United States
- San Diego, United States
- Santa Ana, United States
- Torrance, United States
- Yorba Linda, United States
- Hialeah, United States
- Hollywood, United States
- Miami, United States
- Miami Springs, United States
- Orlando, United States
- Decatur, United States
- Chicago, United States
- Winfield, United States
- Shreveport, United States
- St Louis, United States
- Berlin, United States
- Jamaica, United States
- Charlotte, United States
- Cincinnati, United States
- DeSoto, United States
- Richardson, United States
- Rijeka, Croatia
- Dnipro, Ukraine
- Kharkiv, Ukraine
- Kherson, Ukraine
- Kyiv, Ukraine
- Lviv, Ukraine
- Oleksandrivka, Ukraine
- Poltava, Ukraine
- Ternopil, Ukraine
- Vinnytsia, Ukraine
Questions about this study
What did researchers investigate?
Researchers compared Brexpiprazole and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.
Who is behind this study?
The study sponsor is Otsuka Pharmaceutical Development & Commercialization, Inc., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including Brexpiprazole and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
